Showing results (651-660 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanomaPaul Monk, Elaine Lam, Amir Mortazavi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
Regression of metastatic clear cell kidney cancer with interleukin-2 treatment following nivolumab (anti-PD-1) treatmentJason Brayer, Mayer FishmanJournal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12Shigui Zhu, Benoit J Van den Eynde, Pierre G Coulie, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2Richard W Joseph, Jeanette E Eckel-Passow, Ruchi Sharma, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanomaTravis B Kidner, Donald L Morton, Delphine J Lee, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Combination of cyclophosphamide, rituximab, and intratumoral CpG oligodeoxynucleotide successfully eradicates established B cell lymphomaDavid J Betting, Sara A Hurvitz, Kristopher K Steward, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998
Tumor cells induce cytolytic T cells to a single immunodominant mutant peptideP Dubey, S C Meredith, C T Siegel, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 28, 2012
Simultaneous coexpression of memory-related and effector-related genes by individual human CD8 T cells depends on antigen specificity and differentiationBhawna Gupta, Emanuela M Iancu, Philippe O Gannon, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
AIM-2: a novel tumor antigen is expressed and presented by human glioma cellsGentao Liu, John S Yu, Gang Zeng, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigenHung T Khong, James C Yang, Suzanne L Topalian, et al.Pageof 176